Royce & Associates LP Buys 44,505 Shares of BrightSpring Health Services, Inc. $BTSG

Royce & Associates LP lifted its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 32.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 182,538 shares of the company’s stock after buying an additional 44,505 shares during the quarter. Royce & Associates LP owned approximately 0.10% of BrightSpring Health Services worth $5,396,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. EverSource Wealth Advisors LLC bought a new stake in BrightSpring Health Services in the 2nd quarter valued at $43,000. CWM LLC grew its position in shares of BrightSpring Health Services by 105.3% during the third quarter. CWM LLC now owns 1,595 shares of the company’s stock valued at $47,000 after purchasing an additional 818 shares in the last quarter. Amalgamated Bank increased its holdings in shares of BrightSpring Health Services by 62.7% in the third quarter. Amalgamated Bank now owns 3,041 shares of the company’s stock worth $90,000 after purchasing an additional 1,172 shares during the last quarter. Sandia Investment Management LP bought a new stake in shares of BrightSpring Health Services in the second quarter worth about $118,000. Finally, Penserra Capital Management LLC purchased a new stake in shares of BrightSpring Health Services in the second quarter worth about $139,000.

BrightSpring Health Services Stock Performance

NASDAQ BTSG opened at $41.96 on Thursday. The business’s 50 day moving average price is $39.34 and its 200-day moving average price is $33.72. BrightSpring Health Services, Inc. has a fifty-two week low of $15.48 and a fifty-two week high of $44.87. The company has a market cap of $8.12 billion, a P/E ratio of 47.68, a P/E/G ratio of 0.56 and a beta of 2.31. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.12 and a current ratio of 1.57.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings data on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.01). BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The firm had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.38 billion. During the same quarter last year, the firm earned $0.11 EPS. The company’s revenue was up 29.3% on a year-over-year basis. Sell-side analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.

Key Headlines Impacting BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Morgan Stanley raised its price target to $48 and kept an “overweight” rating, signaling institutional confidence and giving investors a visible upside reference. Morgan Stanley Raises PT
• Positive Sentiment: Mizuho bumped its target to $50 with an “outperform” rating, another upward revision that supports buyer interest. Mizuho Raises PT
• Positive Sentiment: Wells Fargo increased its price target to $50, adding to analyst-driven upward pressure on the stock. Wells Fargo Raises PT
• Positive Sentiment: Zacks placed BTSG on its Rank #1 (Strong Buy) momentum list and published bullish commentary highlighting recent fast-paced momentum at a reasonable valuation — coverage that can attract momentum and retail flows. Zacks Momentum Pick
• Positive Sentiment: Additional Zacks coverage framed BTSG as a value/momentum opportunity, which may further widen the buyer base (value and momentum investors). Zacks Value/Momentum Analysis
• Neutral Sentiment: Short-interest data reported for early March is inconsistent/zero in the filings (reports show 0 shares and 0 days-to-cover), so it doesn’t provide a reliable signal for current short pressure or covering dynamics.
• Negative Sentiment: Secondary offering priced: existing shareholders (including a KKR affiliate and some management) are selling 20,000,000 shares at $41.15 per share; BrightSpring is not selling shares and receives no proceeds. The large block sale increases available float and likely added selling pressure/volume around the offering close, even though the company itself isn’t diluting equity. Secondary Offering & Repurchase

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. BTIG Research restated a “buy” rating and set a $55.00 price target on shares of BrightSpring Health Services in a report on Monday. Bank of America upped their price objective on BrightSpring Health Services from $38.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. TD Cowen reissued a “buy” rating on shares of BrightSpring Health Services in a report on Monday. Mizuho boosted their price target on shares of BrightSpring Health Services from $45.00 to $50.00 and gave the stock an “outperform” rating in a research report on Tuesday. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of BrightSpring Health Services in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $44.08.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.